other

Glypican-3

Cell-surface protein carried by many liver cancers and some other tumours but largely absent from healthy mature liver cells, which makes it a candidate target antigen for engineered cell therapies.

Known aliases

GPC3
GPC3+

Relationships

No evidence-backed relationships are recorded.

Current clusters

product1 publisher

Two outpatient CAR T infusions put a 3-year-old's metastatic liver cancer into remission for a year

A 3-year-old whose liver cancer outlasted surgery and three lines of chemotherapy has been in complete remission for a year after CAR T cells given entirely in the outpatient setting, Baylor doctors report.

Publishers:gizmodo.com

Reality

Evidence62
Adoption8
Hype gap+30
Incentives55
Confidence48